# FDA Inspection 1218049 - Lupin Limited (Unit II) - August 11, 2023

Source: https://www.keypedia.com/records/fda_inspections/lupin-limited-unit-ii/d6691a54-1658-4c0c-9b0c-394bcb5e8740
Source feed: FDA_Inspections

> FDA Inspection 1218049 for Lupin Limited (Unit II) on August 11, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1218049
- Company Name: Lupin Limited (Unit II)
- Inspection Date: 2023-08-11
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1076397 - 2018-12-04](https://www.keypedia.com/records/fda_inspections/lupin-limited-unit-ii/c01a7e9b-7a13-4cc4-b966-080791f4c5a4)
- [FDA Inspection 984036 - 2016-08-12](https://www.keypedia.com/records/fda_inspections/lupin-limited-unit-ii/097be89c-7a97-4aff-b3f9-fdd19f0d919d)

Company: https://www.keypedia.com/companies/lupin-limited-unit-ii/0e413a24-2509-480e-8fc5-4b107772370e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c